ZA884484B - Essential fatty acid compositions - Google Patents

Essential fatty acid compositions

Info

Publication number
ZA884484B
ZA884484B ZA884484A ZA884484A ZA884484B ZA 884484 B ZA884484 B ZA 884484B ZA 884484 A ZA884484 A ZA 884484A ZA 884484 A ZA884484 A ZA 884484A ZA 884484 B ZA884484 B ZA 884484B
Authority
ZA
South Africa
Prior art keywords
fatty acid
essential fatty
acid compositions
acid
acid selected
Prior art date
Application number
ZA884484A
Other languages
English (en)
Inventor
David Frederick Horrobin
Frederick Horrobin David
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA884484B publication Critical patent/ZA884484B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
ZA884484A 1987-06-24 1988-06-23 Essential fatty acid compositions ZA884484B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878714772A GB8714772D0 (en) 1987-06-24 1987-06-24 Essential fatty acid compositions

Publications (1)

Publication Number Publication Date
ZA884484B true ZA884484B (en) 1989-03-29

Family

ID=10619463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884484A ZA884484B (en) 1987-06-24 1988-06-23 Essential fatty acid compositions

Country Status (13)

Country Link
EP (1) EP0296751B1 (de)
JP (1) JPH0788301B2 (de)
KR (1) KR960010832B1 (de)
AT (1) ATE81453T1 (de)
AU (1) AU608012B2 (de)
CA (1) CA1310911C (de)
DE (1) DE3875286T2 (de)
ES (1) ES2045120T4 (de)
GB (1) GB8714772D0 (de)
GR (1) GR3006403T3 (de)
HK (1) HK158496A (de)
IE (1) IE63386B1 (de)
ZA (1) ZA884484B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729751D0 (en) * 1987-12-21 1988-02-03 Norsk Hydro As Feed additive & feed containing such additive
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
WO1992012711A1 (en) * 1991-01-24 1992-08-06 Martek Corporation Microbial oil mixtures and uses thereof
US5262162A (en) 1991-09-06 1993-11-16 Merz & Co. Gmbh & Co. Cerebral-activating extract
JPH0717855A (ja) * 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
GB9301629D0 (en) * 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids
JPH07122071B2 (ja) * 1993-02-23 1995-12-25 工業技術院長 オクタデカテトラエン酸を構成成分として含有する物質の製造方法
PT755633E (pt) * 1995-07-28 2000-04-28 Hamm Prof Dr Michael Preparacao bifasica
US6913916B1 (en) 1998-09-02 2005-07-05 Abbott Laboratories Elongase genes and uses thereof
US6403349B1 (en) * 1998-09-02 2002-06-11 Abbott Laboratories Elongase gene and uses thereof
US20030163845A1 (en) 1998-09-02 2003-08-28 Pradip Mukerji Elongase genes and uses thereof
US6677145B2 (en) * 1998-09-02 2004-01-13 Abbott Laboratories Elongase genes and uses thereof
GB9901808D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Drugs for treatment of psychiatric and brain disorders
US7070970B2 (en) 1999-08-23 2006-07-04 Abbott Laboratories Elongase genes and uses thereof
KR20020073580A (ko) * 2000-02-09 2002-09-27 바스프 악티엔게젤샤프트 신규 연장효소 유전자 및 다가불포화 지방산의 제조 방법
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
JP5496163B2 (ja) * 2011-10-19 2014-05-21 サントリーホールディングス株式会社 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
JP2014141437A (ja) * 2013-01-24 2014-08-07 Oriza Yuka Kk 学習記憶改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition

Also Published As

Publication number Publication date
IE63386B1 (en) 1995-04-19
KR890000085A (ko) 1989-03-11
IE881828L (en) 1988-12-24
EP0296751B1 (de) 1992-10-14
GB8714772D0 (en) 1987-07-29
ES2045120T3 (es) 1994-01-16
AU1821888A (en) 1989-01-05
ATE81453T1 (de) 1992-10-15
HK158496A (en) 1996-08-30
KR960010832B1 (ko) 1996-08-09
JPS6422819A (en) 1989-01-25
AU608012B2 (en) 1991-03-21
CA1310911C (en) 1992-12-01
ES2045120T4 (es) 1996-07-16
DE3875286T2 (de) 1993-03-11
GR3006403T3 (de) 1993-06-21
JPH0788301B2 (ja) 1995-09-27
DE3875286D1 (de) 1992-11-19
EP0296751A1 (de) 1988-12-28

Similar Documents

Publication Publication Date Title
GB8714772D0 (en) Essential fatty acid compositions
HK37694A (en) Fatty acids compositions
ES2060290T3 (es) Composiciones de acidos grasos esenciales (efa) y terapia.
GB2221843B (en) Fatty acid composition
GR3025178T3 (en) Medicament for the treatment of vulvar dystrophy or vaginal dryness
GB9012651D0 (en) Essential fatty acid treatment
EP0295954A3 (en) Compositions for the treatment of periodontal disease
DE3366506D1 (en) Pharmaceutical composition
DE3484606D1 (en) Deodorant.
TW223589B (de)
GB8516906D0 (en) Pharmaceutical & dietary composition